Table 1 Serology titres and perinatal complications of 19 women with Q fever among 179 pregnant women with adverse pregnancy outcomes (APO), Saint Pierre, May to October 2013
From: Pregnancy outcomes of Q fever: prospective follow-up study on Reunion island
Patient | Age range (years) | Phase 2 IgM | Phase 2 IgG | Phase 1 IgG | APO (weeks) |
|---|---|---|---|---|---|
1 | 35 to 40 | 48 | 256 | 0 | LPTB (36 weeks) |
2 | 31 to 35 | 96 | 256 | 0 | EM (9 weeks) |
3 | 15 to 20 | 0 | 64 | 0 | SGA + OA (39 weeks) |
4 | 31 to 35 | 0 | 128 | 0 | EM (10 weeks) |
5 | 21 to 25 | 192 | 1024 | 128 | EM (5 weeks) |
6 | 41 to 45 | 0 | 512 | 128 | EM (8 weeks) |
7 | 21 to 25 | 0 | 256 | 0 | NGA (39 weeks) |
8 | 26 to 30 | 0 | 1024 | 0 | EM (8 weeks) |
9 | 36 to 40 | 0 | 256 | 0 | HM + EM (8 weeks) |
10 | 16 to 20 | 0 | 256 | 0 | IUFD+LPTB(36 weeks) |
11 | 16 to 20 | 0 | 64 | 0 | EM (6 weeks) |
12 | 31 to 35 | 0 | 64 | 0 | LM (21 weeks) |
13 | 16 to 20 | 0 | 64 | 0 | LPTB+SGA (36 weeks) |
14 | 41 to 45 | 0 | 128 | 0 | EM (9 weeks) |
15 | 31 to 35 | 0 | 256 | 0 | IUFD+VPTB (32 weeks) |
16 | 36 to 40 | 0 | 128 | 0 | EM (9 weeks) |
17 | 26 to 30 | 0 | 64 | 0 | VPTB+SGA (31 weeks) |
18 | 36 to 40 | 0 | 256 | 0 | SGA (39 weeks) |
19 | 21 to 25 | 0 | 128 | 0 | SGA (37 weeks) |